Symbol="MORF"
AssetType="Common Stock"
Name="Morphic Holding Inc"
Description="Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small molecule integrin therapies for the treatment of autoimmune, cardiovascular, metabolic, fibrosis, and cancer diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1679363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="35 GATEHOUSE DRIVE A2, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2640050000"
EBITDA="-141562000"
PERatio="None"
PEGRatio="None"
BookValue="15.23"
DividendPerShare="0"
DividendYield="0"
EPS="-3.28"
RevenuePerShareTTM="0.218"
ProfitMargin="0"
OperatingMarginTTM="-16.37"
ReturnOnAssetsTTM="-0.153"
ReturnOnEquityTTM="-0.232"
RevenueTTM="8711000"
GrossProfitTTM="-31254000"
DilutedEPSTTM="-3.28"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.781"
AnalystTargetPrice="74.78"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="14.03"
PriceToBookRatio="2.901"
EVToRevenue="9.32"
EVToEBITDA="-12.06"
Beta="1.094"
num_52WeekHigh="63.08"
num_52WeekLow="23.03"
num_50DayMovingAverage="56.55"
num_200DayMovingAverage="43.58"
SharesOutstanding="45825300"
DividendDate="None"
ExDividendDate="None"
symbol="MORF"
open="55.17"
high="56.21"
low="54.21"
price="54.78"
volume="209122.00"
latest_trading_day="2023-08-28"
previous_close="55.09"
change="-0.31"
change_percent="-0.5627%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="18"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="82"
Volume_recent_avg="528463"
Change_recent_avg="0.07"
Delta_recent_avg="2.54"
Variance_recent_avg="1.27"
Change_ratio_recent_avg="0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="82"
Aroon_momentum_negative="18"
image_negative_thumbnail_id_1="1137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0170.jpeg"
image_negative_thumbnail_id_2="100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0076.jpeg"
image_neutral_thumbnail_id_1="539"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_neutral_thumbnail_id_2="577"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_positive_thumbnail_id_1="988"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_positive_thumbnail_id_2="962"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
